Ddd Partners, LLC Adaptive Biotechnologies Corp Transaction History

Ddd Partners, LLC

$809 Million
Q4 2024

A detailed history of Ddd Partners, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Ddd Partners, LLC holds 64,747 shares of ADPT stock, worth $501,789. This represents 0.05% of its overall portfolio holdings.

Number of Shares

64,747

Previous 769,166 91.58%

Holding current value

$501,789

Previous $3.94 Million 90.15%

% of portfolio

0.05%

Previous 0.43%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	SELL	$4.37 - $6.78 $3.08 Million - $4.78 Million	-704,419 Reduced 91.58%	64,747 $388,000
Q3 2024 Nov 12, 2024	SELL	$3.37 - $5.12 $2,800 - $4,254	-831 Reduced 0.11%	769,166 $3.94 Million
Q2 2024 Aug 01, 2024	BUY	$2.34 - $3.96 $70,803 - $119,821	30,258 Added 4.09%	769,997 $2.79 Million
Q1 2024 May 09, 2024	SELL	$2.88 - $4.8 $176,207 - $293,678	-61,183 Reduced 7.64%	739,739 $2.37 Million
Q4 2023 Jan 17, 2024	BUY	$3.46 - $5.33 $59,598 - $91,809	17,225 Added 2.2%	800,922 $3.92 Million
Q3 2023 Oct 18, 2023	BUY	$5.07 - $8.44 $3.97 Million - $6.61 Million	783,697 New	783,697 $4.27 Million
Q4 2021 Jan 24, 2022	SELL	$25.17 - $36.85 $7.98 Million - $11.7 Million	-316,927 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$30.02 - $39.87 $2 Million - $2.65 Million	66,545 Added 26.58%	316,927 $10.8 Million
Q2 2021 Aug 04, 2021	BUY	$32.22 - $44.59 $4.54 Million - $6.28 Million	140,882 Added 128.66%	250,382 $10.2 Million
Q1 2021 May 03, 2021	BUY	$37.26 - $67.74 $55,182 - $100,322	1,481 Added 1.37%	109,500 $4.41 Million
Q4 2020 Feb 09, 2021	BUY	$45.01 - $65.47 $228,245 - $331,998	5,071 Added 4.93%	108,019 $6.39 Million
Q3 2020 Oct 28, 2020	BUY	$35.79 - $48.81 $3.68 Million - $5.02 Million	102,948 New	102,948 $5.01 Million

Others Institutions Holding ADPT

# of Institutions

202

Shares Held

144M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $1.11B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ddd Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ddd Partners, LLC with notifications on news.

Account